Credit Suisse’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-50,000
Closed -$1.51M 4204
2016
Q3
$1.51M Buy
+50,000
New +$1.51M ﹤0.01% 2599

Other funds holding RGEN

Credit Suisse's RGEN Position: Q1 2024 in Review

Credit Suisse reduced its Repligen (RGEN) stake by 10% in Q1 2024, selling an estimated $1.9M and leaving 85,380 shares worth $15.7M. The position accounts for 0.02% of the portfolio, ranked #715.

Credit Suisse first reported a position in RGEN in Q2 2013 and has held it in 44 quarters since. The position peaked at $17.6M in Q3 2021. 486 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Credit Suisse held 85,380 shares of Repligen worth $15.7M as of Q1 2024.
  • Credit Suisse sold 9,969 Repligen shares in Q1 2024, an estimated $1.9M.
  • Repligen made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #715 holding.
  • Credit Suisse first reported a position in Repligen in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Repligen position peaked at $17.6M in Q3 2021.
  • 486 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.